Potential therapeutic agents that raise high-density lipoprotein cholesterol levels

Author： Rodriguez Annabelle Doshi Rajiv R

ISSN： 1354-3776

Source： Expert Opinion on Therapeutic Patents, Vol.13, Iss.2, 2003-02, pp. : 167-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Should We Take High-Density Lipoprotein Cholesterol Levels at Face Value?

By > >

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 1, 2010-02 ,pp. : 1-3

Adis International

Access to resources Recommend Favorite

Emerging Strategies and Agents to Lower Cardiovascular Risk by Increasing High Density Lipoprotein Cholesterol Levels

Current Medicinal Chemistry, Vol. 16, Iss. 2, 2009-01 ,pp. : 144-156

Bentham Science Publishers

Access to resources Recommend Favorite

Micronized Fenofibrate in Dyslipidemia: A Focus on Plasma High-Density Lipoprotein Cholesterol (HDL-C) Levels

By Sharpe M. Ormrod D. Jarvis B.

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 2, 2002-02 ,pp. : 125-132

Adis International

Access to resources Recommend Favorite

Therapeutic use of the high-density lipoprotein protein and peptides

By Marchesi Marta Sirtori Cesare R

Expert Opinion on Investigational Drugs, Vol. 15, Iss. 3, 2006-03 ,pp. : 227-241

Informa Healthcare

Access to resources Recommend Favorite

Optimal Therapy of Low Levels of High Density Lipoprotein-Cholesterol

By Kashyap M.L.

American Journal of Cardiovascular Drugs, Vol. 3, Iss. 1, 2003-01 ,pp. : 53-65

Adis International

Access to resources Recommend Favorite